sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Alcaftadine

Alcaftadine

CAS No.:
147084-10-4
Catalog Number:
AG019FUT
Molecular Formula:
C19H21N3O
Molecular Weight:
307.3895
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
95%
In Stock USA
United States
$101
- +
10mg
95%
In Stock USA
United States
$132
- +
25mg
95%
In Stock USA
United States
$268
- +
50mg
95%
In Stock USA
United States
$376
- +
100mg
95%
In Stock USA
United States
$510
- +
Product Description
Catalog Number:
AG019FUT
Chemical Name:
Alcaftadine
CAS Number:
147084-10-4
Molecular Formula:
C19H21N3O
Molecular Weight:
307.3895
MDL Number:
MFCD09954106
IUPAC Name:
11-(1-methylpiperidin-4-ylidene)-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde
InChI:
InChI=1S/C19H21N3O/c1-21-9-6-15(7-10-21)18-17-5-3-2-4-14(17)8-11-22-16(13-23)12-20-19(18)22/h2-5,12-13H,6-11H2,1H3
InChI Key:
MWTBKTRZPHJQLH-UHFFFAOYSA-N
SMILES:
O=Cc1cnc2n1CCc1c(C2=C2CCN(CC2)C)cccc1
UNII:
7Z8O94ECSX
Properties
Complexity:
479  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
307.168g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
307.397g/mol
Monoisotopic Mass:
307.168g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
38.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.7  
Literature
Title Journal
New drugs 2012 part I. Nursing 20120301
Alcaftadine for the prevention of itching associated with allergic conjunctivitis. The Annals of pharmacotherapy 20120101
Histamine and H1-antihistamines: celebrating a century of progress. The Journal of allergy and clinical immunology 20111201
Alcaftadine: a topical antihistamine for use in allergic conjunctivitis. Drugs of today (Barcelona, Spain : 1998) 20111201
Clinical pharmacology of alcaftadine, a novel antihistamine for the prevention of allergic conjunctivitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110401
Alcaftadine (Lastacaft) for allergic conjunctivitis. The Medical letter on drugs and therapeutics 20110307
The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis. Current medical research and opinion 20110301
Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%. Clinical ophthalmology (Auckland, N.Z.) 20110101
Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis. Drug design, development and therapy 20110101
Vilazodone hydrochloride, linagliptin, and alcaftadine. Journal of the American Pharmacists Association : JAPhA 20110101
Properties